Literature DB >> 31796306

Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort.

Nicholas Massa1, Andrew V Owens2, Wesley Harmon3, Arpita Bhattacharya4, Elena I Ivleva5, Sarah Keedy6, John A Sweeney7, Godfrey D Pearlson8, Matcheri S Keshavan9, Carol A Tamminga5, Brett A Clementz10, Erica Duncan11.   

Abstract

BACKGROUND: Latency of the acoustic startle reflex is the time from presentation of the startling stimulus until the response and provides an index of neural processing speed. Latency is prolonged in schizophrenia, is 90% heritable, and predicts conversion to schizophrenia in a high-risk population. The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) consortium investigates neurobiological features found in psychotic disorders spanning diagnostic criteria for schizophrenia (SCZ), schizoaffective disorder (SAD), and psychotic bipolar disorder (BP). We investigated whether differences in startle latency and prepulse inhibition (PPI) occur in probands, their first-degree relatives, and neurobiologically defined subgroups of the probands (Biotypes).
METHODS: 1143 subjects were included from the B-SNIP cohort: 143 with SCZ, 178 SCZ relatives (SCZ-Fam), 123 with SAD, 152 SAD relatives (SAD-Fam), 138 BP, 183 BP relatives (BP-Fam), and 226 controls (CON). A Biopac system recorded the eyeblink component of the startle reflex during startle testing.
RESULTS: Latency differed by diagnosis (F(3,620) = 5.10, p = 0.002): SCZ, SAD, and BP probands had slower latency than CON, with relatives intermediate. Biotypes 1 and 2 had slower latency than CON (p < 0.031) but Biotype 3 did not differ from CON. PPI did not separate CON from other subjects when analyzed by diagnoses nor when analyzed by biotype. Biotype 1 relatives had slower latency (F(3,663) = 3.49, p = 0.016) and more impaired PPI than Biotype 2 and 3 relatives (F(3,663) = 2.77, p = 0.041).
CONCLUSION: Startle latency is prolonged in psychotic disorders that cross traditional diagnostic categories. These data suggest a genetic difference between biotypes that span across clinically defined diagnoses. Published by Elsevier B.V.

Entities:  

Keywords:  Acoustic startle; Biotype; Bipolar; Latency; Prepulse inhibition; Schizophrenia

Mesh:

Year:  2019        PMID: 31796306      PMCID: PMC7239737          DOI: 10.1016/j.schres.2019.11.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  57 in total

1.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

2.  Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder.

Authors:  Suzanne Lucia Barrett; Christopher Kelly; David Robert Watson; Robert Bell; David John King
Journal:  Psychol Med       Date:  2005-12       Impact factor: 7.723

3.  Habituation of the Blink reflex in normals and schizophrenic patients.

Authors:  M A Geyer; D L Braff
Journal:  Psychophysiology       Date:  1982-01       Impact factor: 4.016

Review 4.  The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues.

Authors:  A O Hamm; A I Weike; H T Schupp
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.

Authors:  Kathleen R Merikangas; Robert Jin; Jian-Ping He; Ronald C Kessler; Sing Lee; Nancy A Sampson; Maria Carmen Viana; Laura Helena Andrade; Chiyi Hu; Elie G Karam; Maria Ladea; Maria Elena Medina-Mora; Yutaka Ono; Jose Posada-Villa; Rajesh Sagar; J Elisabeth Wells; Zahari Zarkov
Journal:  Arch Gen Psychiatry       Date:  2011-03

7.  Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjects.

Authors:  Wendy Hasenkamp; Mary Kelley; Glenn Egan; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2011-03-11       Impact factor: 3.222

8.  The Economic Burden of Schizophrenia in the United States in 2013.

Authors:  Martin Cloutier; Myrlene Sanon Aigbogun; Annie Guerin; Roy Nitulescu; Agnihotram V Ramanakumar; Siddhesh A Kamat; Michael DeLucia; Ruth Duffy; Susan N Legacy; Crystal Henderson; Clement Francois; Eric Wu
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

Review 9.  Schizophrenia: a concise overview of incidence, prevalence, and mortality.

Authors:  John McGrath; Sukanta Saha; David Chant; Joy Welham
Journal:  Epidemiol Rev       Date:  2008-05-14       Impact factor: 6.222

10.  The dopamine D(3) receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex.

Authors:  Panos Roussos; Stella G Giakoumaki; Panos Bitsios
Journal:  Biol Psychiatry       Date:  2008-03-05       Impact factor: 13.382

View more
  4 in total

1.  Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia.

Authors:  Tiffany A Greenwood; Neal R Swerdlow; Joyce Sprock; Monica E Calkins; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Keith H Nuechterlein; Allen D Radant; Jeremy M Silverman; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff; Erica Duncan
Journal:  Schizophr Res       Date:  2020-11-12       Impact factor: 4.939

2.  Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects.

Authors:  Bradley D Pearce; Nicholas Massa; David R Goldsmith; Zeal H Gandhi; Allison Hankus; Alaaeddin Alrohaibani; Neha Goel; Bruce Cuthbert; Molly Fargotstein; Dana Boyd Barr; Parinya Panuwet; Victoria M Brown; Erica Duncan
Journal:  Front Psychiatry       Date:  2020-11-20       Impact factor: 4.157

3.  Detection of Schizophrenia Cases From Healthy Controls With Combination of Neurocognitive and Electrophysiological Features.

Authors:  Qing Tian; Ning-Bo Yang; Yu Fan; Fang Dong; Qi-Jing Bo; Fu-Chun Zhou; Ji-Cong Zhang; Liang Li; Guang-Zhong Yin; Chuan-Yue Wang; Ming Fan
Journal:  Front Psychiatry       Date:  2022-04-05       Impact factor: 5.435

4.  Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.

Authors:  Kristin S Cadenhead; Erica Duncan; Jean Addington; Carrie Bearden; Tyrone D Cannon; Barbara A Cornblatt; Dan Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Peter Bauchman; Ayse Belger; Ricardo E Carrión; Franc Donkers; Jason Johannesen; Gregory Light; Margaret Niznikiewicz; Jason Nunag; Brian Roach
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.